{"id":48141,"date":"2022-09-08T21:01:53","date_gmt":"2022-09-08T19:01:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/"},"modified":"2022-09-08T21:01:53","modified_gmt":"2022-09-08T19:01:53","slug":"north-haven-capital-announces-acquisition-of-the-chamberlain-group","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/","title":{"rendered":"North Haven Capital Announces Acquisition of The Chamberlain Group"},"content":{"rendered":"
\n

PORTLAND, Maine–(BUSINESS WIRE)–North Haven Capital (NHC), a private investment group based in Portland, Maine announced today that it has acquired New England-based Chamberlain Group (TCG). NHC teamed up with BankProv, a future-ready commercial bank that offers adaptive and technology-first banking solutions to emerging markets and BDC Capital, recognized locally and nationally as a leader and innovator in business lending and capital investment. Upstream Capital assisted in originating the transaction.\n<\/p>\n

<\/a><\/p>\n

\nThe Chamberlain Group is a leading designer, developer, and manufacturer of anatomical medical models, providing the best alternative to animals and cadavers for emerging medical device training and the associated procedures. NHC identified TCG as a scalable, high quality regional leader that has a global footprint and is ready to drive the expansion of its product offerings, target end markets, and international footprint.\n<\/p>\n

\nSam Sezak, Partner at North Haven Capital, said, \u201cLisa and Eric have built an extremely high-quality firm that takes great pride in its corporate culture and reputation with its client base. We\u2019re excited to work with the employees of TCG to expand their presence geographically and into new products and service offerings.\u201d\n<\/p>\n

\nLisa Chamberlain, founding co-partner of The Chamberlain Group said, \u201cEric and I are excited and pleased to work with North Haven Capital with the shared goals of providing a rewarding environment for our valued team members and increasing our market share both nationally and internationally. The team at North Haven brings energy and enthusiasm for growth and innovation that will serve our present and future clients in our mission of Bringing Practice to the Practice of Medicine.\u201d<\/i>\n<\/p>\n

\nAbout North Haven Capital<\/b>\n<\/p>\n

\nNorth Haven Capital is a family office backed private investment group investing in dynamic, middle market family and owner-operated businesses in northern New England. To maximize shareholder value, the firm utilizes small business values while providing capital resources and proprietary networks to help its businesses achieve growth and profitability potential. With NHC\u2019s long-term investment horizon, they focus primarily on control acquisitions of businesses with a proven track record of success.\n<\/p>\n

\nAbout The Chamberlain Group<\/b>\n<\/p>\n

\nThe Chamberlain Group designs, develops, and manufactures high fidelity mimetic anatomy for surgical and interventional training, research, device development, and sales and marketing. The team collaborates with medical device companies and teaching hospitals in over 60 countries, developing and manufacturing products that span all levels, from simple suturing to complex procedural instruction.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSam Sezak
\n
Partner
\n
Sam@northhavencapital.com<\/a>
917-744-8170\n<\/p>\n

\nDrew Bagin
\n
Partner
\n
Drew@northhavencapital.com<\/a>
207-233-8871\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PORTLAND, Maine–(BUSINESS WIRE)–North Haven Capital (NHC), a private investment group based in Portland, Maine announced today that it has acquired New England-based Chamberlain Group (TCG). NHC teamed up with BankProv, a future-ready commercial bank that offers adaptive and technology-first banking solutions to emerging markets and BDC Capital, recognized locally and nationally as a leader and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48141","6":"format-standard","7":"category-industry"},"yoast_head":"\nNorth Haven Capital Announces Acquisition of The Chamberlain Group - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"North Haven Capital Announces Acquisition of The Chamberlain Group - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PORTLAND, Maine–(BUSINESS WIRE)–North Haven Capital (NHC), a private investment group based in Portland, Maine announced today that it has acquired New England-based Chamberlain Group (TCG). NHC teamed up with BankProv, a future-ready commercial bank that offers adaptive and technology-first banking solutions to emerging markets and BDC Capital, recognized locally and nationally as a leader and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-08T19:01:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220908005116\/en\/1563275\/21\/NHC_Logo_PNG.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"North Haven Capital Announces Acquisition of The Chamberlain Group\",\"datePublished\":\"2022-09-08T19:01:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\\\/\"},\"wordCount\":420,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005116\\\/en\\\/1563275\\\/21\\\/NHC_Logo_PNG.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\\\/\",\"name\":\"North Haven Capital Announces Acquisition of The Chamberlain Group - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005116\\\/en\\\/1563275\\\/21\\\/NHC_Logo_PNG.jpg\",\"datePublished\":\"2022-09-08T19:01:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005116\\\/en\\\/1563275\\\/21\\\/NHC_Logo_PNG.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005116\\\/en\\\/1563275\\\/21\\\/NHC_Logo_PNG.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"North Haven Capital Announces Acquisition of The Chamberlain Group\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"North Haven Capital Announces Acquisition of The Chamberlain Group - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/","og_locale":"en_US","og_type":"article","og_title":"North Haven Capital Announces Acquisition of The Chamberlain Group - Pharma Trend","og_description":"PORTLAND, Maine–(BUSINESS WIRE)–North Haven Capital (NHC), a private investment group based in Portland, Maine announced today that it has acquired New England-based Chamberlain Group (TCG). NHC teamed up with BankProv, a future-ready commercial bank that offers adaptive and technology-first banking solutions to emerging markets and BDC Capital, recognized locally and nationally as a leader and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-08T19:01:53+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220908005116\/en\/1563275\/21\/NHC_Logo_PNG.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"North Haven Capital Announces Acquisition of The Chamberlain Group","datePublished":"2022-09-08T19:01:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/"},"wordCount":420,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005116\/en\/1563275\/21\/NHC_Logo_PNG.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/","url":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/","name":"North Haven Capital Announces Acquisition of The Chamberlain Group - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005116\/en\/1563275\/21\/NHC_Logo_PNG.jpg","datePublished":"2022-09-08T19:01:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220908005116\/en\/1563275\/21\/NHC_Logo_PNG.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220908005116\/en\/1563275\/21\/NHC_Logo_PNG.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/north-haven-capital-announces-acquisition-of-the-chamberlain-group\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"North Haven Capital Announces Acquisition of The Chamberlain Group"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48141"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48141\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}